linkedin post 2013-03-23 02:15:44

Uncategorized
WHAT STRATEGY FOR A NEW US TEST? FDA KIT APPROVAL, OR THE CLIA ROUTE? I have seen some phenomenal strategic errors in this area (names withheld); the best blooper was a set of tests that took a decade and close to 100 M USD in the FDA KIT approval process. This same set of tests would have taken only a matter of months and a few thousand dollars to launch in a CLIA Approved reference lab. If you want an OTC test, there may be reasons to go the FDA route, but rarely does it make sense. Don't become another case study of a flawed strategy! View in LinkedIn
Read More

linkedin post 2013-03-25 06:19:58

Uncategorized
AT A GLANCE, OBESITY IS RARELY SEEN IN SPAIN, and I wondered whether it was due to portion sizes. No, large restaurant portions are not at all uncommon. We have all heard about the Mediterranean diet, but it misses part of the point: meals are slow and social events. A rushed lunch is one and a half hours, a leisurely one perhaps three or four. Never is a meal taken behind a steering wheel or a coffee drunk on the run. Rarely are sodas consumed, and wine is always accompanied by water. In this family-centric culture, they surely are doing something right: a stress reduced lifestyle. http://lnkd.in/jTrR7h View in LinkedIn
Read More

linkedin post 2013-03-25 05:54:34

Uncategorized
ANAPHYLAXIS FROM FOOD ALLERGIES is a rare but serious and life-threatening condition, treated by IM epinephrine injection. In reality, a large proportion of diagnosed (at risk) patients either do not fill the script for an auto-injector, or do not use it in an emergency. Many believe they can simply avoid the allergen, which is harder than it may appear, or do not know how to use the device, or are squeamish about needles. These patients are treated in the Emergency Department. This study of food allergens is long overdue, as are alternatives to EpiPen. http://www.foodproductdesign.com/news/2013/03/largest-study-on-food-allergies-begins.aspx?goback=%2Egde_2541_member_225705292 View in LinkedIn
Read More

linkedin post 2013-03-25 05:40:09

Uncategorized
BURN-OUT IS REAL IN STARTUPS, and the consequences can be truly devastating. A very driven individual risks severe overwork, that results in chronic exhaustion, sleep disturbance, irritability, poor judgement, illness, nervous breakdowns, and depression. Early signs include lack of humor, a short temper, and unrealistic expectations. In the worst cases, this can destroy a business, as well as relationships. It is critical for mentors, colleagues, and board members to watch for symptoms and step in to break the cycle before it gets out of control. View in LinkedIn
Read More

linkedin post 2013-03-24 08:10:26

Uncategorized
AN ARTICLE SUGGESTING THAT DIFFERENT THINKING IN PHARMA would be valuable, and engaging teams like those inside companies like Google could yield good results. It is true that the typical corporate strategy in Pharma is old hat, and that the tasks at hand are hard: it would be interesting to see fresh thinking, but this is only likely to come from smaller and younger ventures. http://lnkd.in/yNdSA9 View in LinkedIn
Read More

linkedin post 2013-03-23 17:35:16

Uncategorized
CATALUNYA HAS ABOUT 46,000 R&D staff and Barcelona has a worldwide ranking of No 12 in terms of scientific production, making it No 5 in Europe. By contrast, Boston ranks No 6 worldwide in scientific production. Catalunya boasts world class facilities including a brand new Synchrotron, two Supercomputing centers, and a Nuclear Magnetic Resonance Lab among others. View in LinkedIn
Read More